Would you treat with consolidative SBRT for oligometastatic liver mets from HER2+ breast cancer if these lesions demonstrated radiographic CR/near-CR following neoadjuvant TCHP chemotherapy (and patient is receiving ongoing adjuvant HP therapy)?

1 Answers

Mednet Member

Radiation Oncology · Varian Medical Systems/Allegheny health network

I would not if radiographic CR or near CR. If there any suspicions of residual disease vs. scar, favor surgery, which will establish diagnosis and also take care of oligomets.

Would you treat with consolidative SBRT for oligometastatic liver mets from HER2+ breast cancer if these lesions demonstrated radiographic CR/near-CR following neoadjuvant TCHP chemotherapy (and patient is receiving ongoing adjuvant HP therapy)? | Mednet